Literature DB >> 2253219

Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.

K Miyazaki1, Y Hattori, F Umenishi, H Yasumitsu, M Umeda.   

Abstract

A metalloproteinase with Mr 29,000 was purified to homogeneity as a latent proenzyme from the conditioned medium of a human rectal carcinoma cell line CaR-1. This enzyme hydrolyzed casein more potently than gelatin embedded in polyacrylamide gels in zymography assay. Calcium ion was essential for the activity. It exerted the maximum activity at pH 7-9. Its activity was stimulated by organomercurials, such as p-amino-phenyl mercuric acetate and p-chloromercuric benzoic acid, and was inhibited by 1,10-phenanthroline but was hardly affected by diisopropyl fluorophosphate and pepstatin. When the purified proenzyme was activated by the organomercurials, it effectively hydrolyzed fibronectin, laminin, type IV basement membrane collagen, and several types of gelatins but not interstitial type I and III collagens. The treatment of the purified proenzyme with p-aminophenyl mercuric acetate or trypsin formed an active peptide with Mr 20,000. The structural analysis indicated that it was most likely identical to putative metalloproteinase-1, the complementary DNA of which had been cloned from human tumor mRNAs capable of hybridizing to a rat transin complementary DNA. Based on the fact that this enzyme is secreted extracellularly and degrades the matrix proteins, we propose the name "matrin" for this newly identified enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253219

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

Authors:  G Murphy; M I Cockett; R V Ward; A J Docherty
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Computational sequence analysis of matrix metalloproteinases.

Authors:  Q A Sang; D A Douglas
Journal:  J Protein Chem       Date:  1996-02

3.  Stimulation of cellular growth and adhesion to fibronectin and vitronectin in culture and tumorigenicity in nude mice by overexpression of trypsinogen in human gastric cancer cells.

Authors:  S Miyata; Y Miyagi; N Koshikawa; Y Nagashima; Y Kato; H Yasumitsu; F Hirahara; K Misugi; K Miyazaki
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

4.  Featured Article: Nanoenhanced matrix metalloproteinase-responsive delivery vehicles for disease resolution and imaging.

Authors:  Donald A McCarthy; Ahmad A Nazem; James McNeilan; Nicole L Shakerley; Ryan R Clark; María D Idelchik; Mehmet Yigit; J Andrés Melendez
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-29

5.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

6.  Expressions of matrix metalloproteinase-7 and -9 and their prognostic significances in rectal cancer.

Authors:  Young Rak Cho; Hyuk-Chan Kwon; Sung-Hwan Suh; Jong Hoon Lee; Sung-Hyun Kim; Hong-Jo Choi; Hyung-Sik Lee; Mee Sook Roh; Tae-Ho Hwang; Jae-Seok Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

7.  Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.

Authors:  A Senota; F Itoh; H Yamamoto; Y Adachi; Y Hinoda; K Imai
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

8.  Vitronectin secretion by hepatic and non-hepatic human cancer cells.

Authors:  H Yasumitsu; N Seo; E Misugi; H Morita; K Miyazaki; M Umeda
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

9.  MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells.

Authors:  Yu-Jing Fang; Zhi-Zhong Pan; Li-Ren Li; Zhen-Hai Lu; Li-Yi Zhang; De-Sen Wan
Journal:  J Exp Clin Cancer Res       Date:  2009-09-29

10.  Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma.

Authors:  Ivy A W Ho; Kelly Y W Chan; Wai-Hoe Ng; Chang M Guo; Kam M Hui; Philip Cheang; Paula Y P Lam
Journal:  Stem Cells       Date:  2009-06       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.